Mylissa Borek
-
- Protein Degradation and Inhibitors 7
- Histone Deacetylase Inhibitors Research 7
- Ubiquitin and proteasome pathways 3
- Cancer therapeutics and mechanisms 1
- Cell death mechanisms and regulation 1
-
- Lung Cancer Treatments and Mutations 2
-
- Cancer, Hypoxia, and Metabolism 2
-
- interferon and immune responses 1
- Co-authors
- Ruzanna AtoyanSteven DellaRoccaGuang-Xin XuMaria SamsonBrian ZifcakChanggeng QianXiong CaiRudi Bao
- Cited by
- Molecular BiologyOncologyGenetics
- Partner nations
- United States
In The Last Decade
Mylissa Borek
10 papers receiving 360 citations
Peers
Comparison fields: 5 of 46
- Molecular Biology 299
- Oncology 109
- Genetics 37
- Hematology 37
- Pathology and Forensic Medicine 44
Countries citing papers authored by Mylissa Borek
This map shows the geographic impact of Mylissa Borek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mylissa Borek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mylissa Borek more than expected).
Fields of papers citing papers by Mylissa Borek
This network shows the impact of papers produced by Mylissa Borek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mylissa Borek. The network helps show where Mylissa Borek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mylissa Borek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 7 | |
| 2 | 2016 | 109 | |
| 3 | 2016 | 4 | |
| 4 | 2014 | 1 | |
| 5 | 2014 | 2 | |
| 6 | 2013 | 2 | |
| 7 | 2012 | 188 | |
| 8 | 2012 | 6 | |
| 9 | 2011 | 1 | |
| 10 | 2009 | 47 |
About Mylissa Borek
Mylissa Borek is a scholar working on Molecular Biology, Cancer Research and Genetics, having authored 10 papers that have together received 367 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (7 papers), Ubiquitin and proteasome pathways (3 papers), Lung Cancer Treatments and Mutations (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer therapeutics and mechanisms (1 paper), interferon and immune responses (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Molecular Biology (299 citations), Oncology (109 citations) and Genetics (37 citations). Mylissa Borek has collaborated with scholars based in United States. Frequent co-authors include Ruzanna Atoyan, Steven DellaRocca, Guang-Xin Xu, Maria Samson, Brian Zifcak, Changgeng Qian, Xiong Cai, Rudi Bao, Cheng-Jung Lai and Da-Gong Wang. Their work appears in journals such as Blood, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.